First experience with BAK-free travoprost 0.004% in topical glaucoma medication

Eitemau Tebyg

• A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
  gan: Godfrey, David A, et al.
  Cyhoeddwyd: (2009)
• Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients
  gan: Miyashiro, Michael J, et al.
  Cyhoeddwyd: (2010)
• Effects of corneal thickness on the intraocular penetration of travoprost 0.004%
  gan: Martinez-de-la-Casa, J M, et al.
  Cyhoeddwyd: (2012)
• Effects of topical travoprost 0.004% on intraocular pressure and corneal biomechanical properties in an animal model
  gan: Lazcano-Gomez, Gabriel, et al.
  Cyhoeddwyd: (2016)
• Intraocular pressure‐lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension
  gan: Noecker, R
  Cyhoeddwyd: (2006)